factor Xa in complex with the dual thrombin-FXa inhibitor 31.
Jérôme Meneyrol(Sanofi (France)), J. M. Herbert, Sylvie Klieber(Sanofi (France)), Z. Böcskei, Markus Follmann(Bayer (Germany)), J.M. Altenburger(Sanofi (France)), L. Millet(Sanofi (France)), C. Hasbrand, C Briot(Sanofi (France)), Herman Schreuder, C. Stehlin-Gaon, T. Rousseaux(Sanofi (France)), Nathalie Alet(Evotec (United States)), Freddy Sadoun(Sanofi (France)), G. Barre(Sanofi (France)), Paul Schaeffer(Universidad La Salle), Frédéric Petit(Sanofi (France)), Jean-P. Hérault, Françoise Bono(OSE Immunotherapeutics (France)), Gilbert Lassalle(Sanofi (France)), F. Dol(Sanofi (France)), Volkmar Wehner(Sanofi (Germany))
Cited by 0
Related Papers
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells
|JCI Insight|2017|444
PGC-1α Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERRα: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism
|Molecular and Cellular Biology|2005|355